- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06525402
Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on Degree of Oral Mucositis in Children Receiving Chemotherapy
March 23, 2025 updated by: Selda Ateş Beşirik, Burdur Mehmet Akif Ersoy University
The Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on The Degree of Oral Mucositis in Children Receiving Chemotherapy: A Randomized Controlled Trial
This study was planned as a randomized controlled experimental study in order to compare the effects of oral care with saline and black mulberry syrup in addition to sodium bicarbonate on oral mucositis level in children aged 6-18 years receiving chemotherapy.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Oral mucositis, also known as stomatitis, is the most common complication of cancer treatment.
Mucositis affects the patient's nutrition, daily functions, and quality of life, may compromise the ability to tolerate scheduled therapy.
For this reason, the children to be included in the study will be randomly divided into three groups.
Sodium bicarbonate, which is the routine care in the clinic, will be administered to the control group, and to the intervention groups, saline in addition to the routine care and black mulberry syrup will be applied in addition to the routine care.
Data will be collected according to Patient Information Form, International Child Mucositis Assessment Scale (ChIMES), World Health Organization Mucositis Classification and neutrophil counts.
Oral care will be applied to the groups 4 times a day for 14 days.
The International Child Mucositis Rating Scale (ChIMES), World Health Organization Mucositis Classification and neutrophil counts will be evaluated by the researchers on the 1st, 2nd, 4th, 8th and 16th days.
Study Type
Interventional
Enrollment (Estimated)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Selda Ateş Beşirik, Assistant Professor
- Phone Number: +905543683323
- Email: seldaates07@gmail.com
Study Locations
-
-
-
Isparta, Turkey
- Recruiting
- Isparta City Hospital
-
Contact:
- Selda Ateş Beşirik, Assistant Prof.
- Phone Number: +905543683323
- Email: seldaates07@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The willingness of the family and the child to participate in the study
- Parent and child have separately informed written consent form
- Be between 6-18 years old
- Receiving chemotherapy and being hospitalized for chemotherapy treatment
- Being fed orally
Exclusion Criteria:
- Oral mucositis in the first intraoral evaluation
- Having diabetes
- Receiving radiotherapy
- Having a surgical procedure in the mouth and jaw area
- Receiving steroid therapy during chemotherapy treatment
- Using a method other than the methods used in the study to protect the oral mucous membrane throughout the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Sodium Bicarbonate Group (Usual care)
General routine oral care.
In the clinic where the research was conducted, a guideline is routinely applied for the care of oral mucositis in line with the stages of oral mucositis.
Sodium bicarbonate is used in line with this guideline.
The first group will receive routine oral care in the clinic with sodium bicarbonate.
It will be applied as a 5 ml mouthwash four times a day, after meals and before going to bed at night.
|
In the clinic where the research was conducted, a guideline is routinely applied for the care of oral mucositis in line with the stages of oral mucositis.
Sodium bicarbonate is used in line with this guideline.
The first group, the control group, will receive routine oral care in the clinic with sodium bicarbonate.
Oral care will be applied 4 times a day for 14 days.
|
|
Experimental: Saline Group
It will be applied as a 5 ml mouthwash four times a day, after meals and before going to bed at night.
|
The second group, the experimental group, will first receive oral care routinely applied in the clinic.
Then, oral care will be given in the form of 5 ml mouthwash with saline.
Oral care will be applied 4 times a day for 14 days.
|
|
Experimental: Black Mulberry Syrup Group
It will be applied as a 5 ml mouthwash four times a day, after meals and before going to bed at night.
|
The third group, the experimental group, will first receive oral care routinely applied in the clinic.
Then black mulberry syrup will be applied.
Then, oral care will be given in the form of 5 ml mouthwash with black mulberry syrup.
Oral care will be applied 4 times a day for 14 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Children's International Mucositis Evaluation Scale
Time Frame: up to 16 days
|
Tomlison et al. (2010) developed Children's International Mucositis Evaluation Scale (ChIMES) in order to evaluate the difficulty experienced by children with cancer due to mouth/throat pain developing depending on mucositis.
Yavuz et al., (2011) conducted the validity and reliability study of the Turkish version of the scale.
The scale consists of six (6) questions and it is an easy-to-apply form that can be answered with the child's facial expressions.
|
up to 16 days
|
|
Oral Mucositis Evaluation Index of the World Health Organization
Time Frame: up to 16 days
|
It is scored between zero and four points.
Although there is no change in the grade-0 mucosa, grade-1 painless ulcers, erythema or mild sensitivity, grade-2 painful erythema and ulcers, solid foods can be consumed.
Grade-3 painful erythema, edema or ulcer can be consumed only, grade-4 ulceration, necrosis and hemorrhage are present, the patient cannot be fed, enteral or parenteral support is required.
|
up to 16 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neutrophil count
Time Frame: up to 16 days
|
The neutrophil count will be evaluated.
Numbers will be recorded.
|
up to 16 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Selda Ateş Beşirik, Assistant Professor, Burdur Mehmet Akif Ersoy University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 30, 2025
Primary Completion (Estimated)
December 30, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
March 29, 2024
First Submitted That Met QC Criteria
July 24, 2024
First Posted (Actual)
July 29, 2024
Study Record Updates
Last Update Posted (Actual)
March 26, 2025
Last Update Submitted That Met QC Criteria
March 23, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/73
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chemotherapy Effect
-
Hospices Civils de LyonCompletedChemotherapy Effect | G-CHOP Chemotherapy | R-CHOP ChemotherapyFrance
-
Namik Kemal UniversityCompleted
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaRecruitingChemotherapy EffectFrance
-
West Cancer CenterPfizer; Emory UniversityCompletedChemotherapy EffectUnited States
-
Rennes University HospitalRecruitingChemotherapy Effect | AplasiaFrance
-
Groupe Hospitalier Paris Saint JosephHopital Antoine BeclereCompletedCancer | Chemotherapy EffectFrance
-
Animated Dynamics, Inc.Purdue UniversityNot yet recruitingCancer | Chemotherapy EffectUnited States
-
Udayana UniversityUnknown
-
Sutter HealthUnknownChemotherapy Effect | Chemotherapeutic Toxicity | FastingUnited States
-
Linhui PengRecruitingHepato Cellular Carcinoma (HCC) | Chemotherapy EffectChina
Clinical Trials on Sodium Bicarbonate Group (Usual care)
-
Guy's and St Thomas' NHS Foundation TrustUniversity of PittsburghActive, not recruiting
-
Ain Shams UniversityCompletedRole of Oral Care in Mechanically Ventilated Preterm InfantsEgypt
-
University of Texas at AustinCompletedCardiovascular Diseases | Hypertension | Chronic Kidney Diseases
-
Johns Hopkins UniversityJohns Hopkins Alliance for a Healthier WorldCompleted
-
Sheba Medical CenterUnknownExtravasation | InfiltrationIsrael
-
University of ArkansasHoward J Barnhard, Resident Research Endowment.; UAMS DEPT of Radiology.Completed
-
Neuromed IRCCSRecruitingMigraine | Chronic Migraine | Episodic Migraine | Musculoskeletal Neck Pain | Musculoskeletal Disorder of the NeckItaly
-
HALEONCompletedGingivitisUnited Kingdom
-
Tanta UniversityCompletedVentilator-Associated PneumoniaEgypt
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedHypertension | Sleep | Blood Pressure | Elevated Blood Pressure | Short Sleep PhenotypeUnited States